Skip to main navigation Skip to search Skip to main content

Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime®

  • E. M. Netto
  • , P. D. Marsden
  • , E. A. Llanos-Cuentas
  • , J. M.L. Costa
  • , C. C. Cuba
  • , A. C. Barreto
  • , R. Badaró
  • , W. D. Johnson
  • , T. C. Jones
  • Brasília University
  • Federal University of Bahia
  • Weill Cornell Medicine

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Abstract

Seventy-nine patients with cutaneous (62) or mucosal (17) infection with Leishmania (Viannia) braziliensis in Três Braços, Bahia, Brazil, were followed for at least 4 years after initiating treatment with antimony. Cutaneous relapses occurred in 6/62 (10%), mucosal relapse after cutaneous infection in 2/62 (3%), and mucosal relapse after mucosal disease in 2/17 (17%). It is concluded that relapse (cutaneous and mucosal) is rare after adequate antimony therapy and that no definite prediction of relapse (clinical, serological or by skin reaction) is possible.

Original languageEnglish
Pages (from-to)367-370
Number of pages4
JournalTransactions of the Royal Society of Tropical Medicine and Hygiene
Volume84
Issue number3
DOIs
StatePublished - Jun 1990
Externally publishedYes

Fingerprint

Dive into the research topics of 'Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime®'. Together they form a unique fingerprint.

Cite this